By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ERYtech Pharma 

60, avenue Rockefeller
Bâtiment Adénine
Lyon    69008  France
Phone: 33-0-4-78-744438 Fax: 33-0-4-78-755629



Company News
ERYtech Pharma Reports First Half 2017 Financial Results And Provides Business Update 9/11/2017 11:42:33 AM
ERYtech Pharma Announces Positive Full Results From Phase IIb Study Of Eryaspase In Combination With Chemotherapy For Treatment Of Metastatic Pancreatic Cancer In Second-Line 9/8/2017 7:00:36 AM
ERYtech PharmaTo Host Second Quarter 2017 Conference Call And Business Update 9/6/2017 11:12:05 AM
ERYtech Pharma To Present Pre-Clinical Data At The 13th International Congress Of Inborn Errors Of Metabolism 9/1/2017 6:48:05 AM
ERYtech Pharma To Present Full Results For Phase IIb Trial Of Eryaspase In Pancreatic Cancer At ESMO 2017 8/31/2017 10:34:51 AM
ERYtech Pharma Announces Collaboration With Queen’s University To Advance Its Product Candidate For Rare Metabolic Disorders 7/12/2017 6:50:51 AM
ERYtech Pharma Provides Business Update And Financial Highlights For Q1 2017 5/19/2017 6:59:54 AM
ERYtech Pharma Announces Launch Of Investigator-Initiated Phase II Study Of Eryaspase (GRASPA) For ALL 4/4/2017 10:31:20 AM
ERYtech Pharma Reports Positive Phase IIb Data For Eryaspase For The Treatment Of Metastatic Pancreatic Cancer 3/27/2017 6:40:38 AM
ERYtech Pharma Collaborates With Fox Chase Cancer Center To Advance Its Platform In The Field Of Rare Metabolic Disorders 3/23/2017 11:54:00 AM